Neutropenic Enterocolitis in Critically Ill Patients: Spectrum of the Disease and Risk of Invasive Fungal Disease.


Journal

Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 12 2 2019
medline: 18 2 2020
entrez: 12 2 2019
Statut: ppublish

Résumé

Neutropenic enterocolitis occurs in about 5.3% of patients hospitalized for hematologic malignancies receiving chemotherapy. Data from critically ill patients with neutropenic enterocolitis are scarce. Our objectives were to describe the population of patients with neutropenic enterocolitis admitted to an ICU and to investigate the risk factors of invasive fungal disease. A multicentric retrospective cohort study between January 2010 and August 2017. Six French ICUs members of the Groupe de Recherche Respiratoire en Onco-Hématologie research network. Adult neutropenic patients hospitalized in the ICU with a diagnosis of enteritis and/or colitis. Patients with differential diagnosis (Clostridium difficile colitis, viral colitis, inflammatory enterocolitis, mesenteric ischemia, radiation-induced gastrointestinal toxicity, and Graft vs Host Disease) were excluded. None. We included 134 patients (median Sequential Organ Failure Assessment 10 [8-12]), with 38.8% hospital mortality and 32.1% ICU mortality rates. The main underlying malignancies were acute leukemia (n = 65, 48.5%), lymphoma (n = 49, 36.6%), solid tumor (n = 14, 10.4%), and myeloma (n = 4, 3.0%). Patients were neutropenic during a median of 14 days (9-22 d). Infection was documented in 81 patients (60.4%), including an isolated bacterial infection in 64 patients (47.8%), an isolated fungal infection in nine patients (6.7%), and a coinfection with both pathogens in eight patients (5.0%). Radiologically assessed enteritis (odds ratio, 2.60; 95% CI, 1.32-7.56; p = 0.015) and HIV infection (odds ratio, 2.03; 95% CI, 1.21-3.31; p = 0.016) were independently associated with invasive fungal disease. The rate of invasive fungal disease reaches 20% in patients with neutropenic enterocolitis when enteritis is considered. To avoid treatment delay, antifungal therapy might be systematically discussed in ICU patients admitted for neutropenic enterocolitis with radiologically assessed enteritis.

Identifiants

pubmed: 30741755
doi: 10.1097/CCM.0000000000003687
doi:

Substances chimiques

Antifungal Agents 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

668-676

Auteurs

Baptiste Duceau (B)

Medical Intensive Care Unit, Hospital Saint Louis, Assistance Publique-Hôpitaux de Paris, France.
Paris Diderot University, Paris, France.

Muriel Picard (M)

Intensive Care Unit, CHU de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.

Romain Pirracchio (R)

Anesthesiology and Surgical Intensive Care Unit, European Hospital Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
Department of Biostatistics and Medical Informatics, INSERM U-1153, Paris, France.

Anne Wanquet (A)

Intensive Care Unit, Paoli-Calmettes Institute, Marseille, France.

Frédéric Pène (F)

Medical Intensive Care Unit, Hospital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.

Sybille Merceron (S)

Intensive Care Unit, Centre Hospitalier de Versailles, Le Chesnay, France.

Djamel Mokart (D)

Intensive Care Unit, Paoli-Calmettes Institute, Marseille, France.

Anne-Sophie Moreau (AS)

Intensive Care Unit, Salengro Hospital, CHU-Lille, Lille, France.

Etienne Lengliné (E)

Department of Hematology, Hospital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.

Emmanuel Canet (E)

Medical Intensive Care Unit, Hospital Saint Louis, Assistance Publique-Hôpitaux de Paris, France.
Paris Diderot University, Paris, France.

Virginie Lemiale (V)

Medical Intensive Care Unit, Hospital Saint Louis, Assistance Publique-Hôpitaux de Paris, France.
Paris Diderot University, Paris, France.

Eric Mariotte (E)

Medical Intensive Care Unit, Hospital Saint Louis, Assistance Publique-Hôpitaux de Paris, France.
Paris Diderot University, Paris, France.

Elie Azoulay (E)

Medical Intensive Care Unit, Hospital Saint Louis, Assistance Publique-Hôpitaux de Paris, France.
Paris Diderot University, Paris, France.

Lara Zafrani (L)

Medical Intensive Care Unit, Hospital Saint Louis, Assistance Publique-Hôpitaux de Paris, France.
Paris Diderot University, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH